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ا رد :ﻪﻣﺪﻘﻣﯾﻦﻧﻮﺧ ﺢﻄﺳ ﻪﻌﻟﺎﻄﻣﯽﺎﻫﺮﮐرﺎﻣيCEA ،CA15-3 وCA27-29ﺳرﺮﺑ نﺎﺘﺴﭘ نﺎﻃﺮﺳ ﻒﻠﺘﺨﻣ ﻞﺣاﺮﻣ ردﯽآ ﻪﮐ دﻮﺷ ﺺﺨﺸﻣ ﺎﺗ ﺪﺷﯾﺎﺑﯿﻦ
ا ﺢﻄﺳﯾﻦرادﺎﻨﻌﻣ طﺎﺒﺗرا نﺎﺘﺴﭘ نﺎﻃﺮﺳ ﻪﻠﺣﺮﻣ و ﺎﻫ ﺮﮐرﺎﻣيﺳرﺮﺑ عﻮﻧ زا ﻪﮐ ﺮﺿﺎﺣ ﻪﻌﻟﺎﻄﻣ رد :ﺎﻫ شور و داﻮﻣ.دراد دﻮﺟوﯽﻌﻄﻘﻣﯽ دﻮﺑ180ﺑﯿرﺎﻤ ﻼﺘﺒﻣﻪﺑ
ﺳرﺮﺑ درﻮﻣ نﺎﺘﺴﭘ نﺎﻃﺮﺳﯽﺎﺘﻧ.ﺖﻓﺮﮔﯾﺞ ﺮﺿﺎﺣ ﻪﻌﻟﺎﻄﻣ رد :57,8%ﺑﯿنارﺎﻤ و هدﻮﺗ ﺖﻠﻋ ﻪﺑ52,8%ﻣ ﺖﻠﻋ ﻪﺑﯿﺴﻠﮐوﺮﮑﯿﻔﯿﺳﺎﮑﯿنﻮﻓاﺮﮔﻮﻣﺎﻣ ردﯽﺳرﺮﺑ ﺖﺤﺗﯽ
 .ﺪﻨﺘﻓﺮﮔ راﺮﻗ25%ﺑﯿنارﺎﻤﻣﺎﻓ ﻪﻘﺑﺎﺳﯿﻠﯽﺑ .ﺪﻨﺘﺷاد ﺖﺒﺜﻣﯿنارﺎﻤا رد ﺮﺿﺎﺣﯾﻦﻣﺎﻤﺗ رد ﻪﻌﻟﺎﻄﻣﯽژﻮﻟﻮﺗﺎﭘ .ﺪﻧدﻮﺑ نﺎﺘﺴﭘ نﺎﻃﺮﺳ ﻞﺣاﺮﻣي70%ﺑﯿنارﺎﻤ لﺎﺘﮐاد
ﺳرﺎﮐﯿمﻮﻨﻘﺑ وﯿﻪد عاﻮﻧا زاﯾﺮﮕ .دﻮﺑ10,5%ﺑﯿنارﺎﻤادﺎﻨﻌﻣ طﺎﺒﺗرا .ﺪﻧدﻮﺑ رﻮﻣﻮﺗ زﺎﺘﺳﺎﺘﻣ ﻪﺑ ﻼﺘﺒﻣريﺑﯿﻦﻣﺮﺳ ﺢﻄﺳﯽCEA وCA15-3 ﻒﻠﺘﺨﻣ ﻞﺣاﺮﻣ و
ﺗﺮﺗ ﻪﺑ )ﺖﺷاد دﻮﺟو نﺎﺘﺴﭘ نﺎﻃﺮﺳﯿﺐP=0.001 وP=0.0001ﻨﭽﻤﻫ .(ﯿﻦرادﺎﻨﻌﻣ طﺎﺒﺗرايﺑﯿﻦﻣﺮﺳ ﺢﻄﺳﯽCA27-29اﺮﻣ وﻞﺣ نﺎﺘﺴﭘ نﺎﻃﺮﺳ ﻒﻠﺘﺨﻣ
ﺘﻧ و ﺚﺤﺑ.ﺖﺷاد دﻮﺟوﯿﻪﺠﮔﯿﺮيﺘﺒﺜﻣ رادﺎﻨﻌﻣ طﺎﺒﺗرا ﺮﺿﺎﺣ ﻪﻌﻟﺎﻄﻣ رد :ﯽﺑﯿﻦﻣﺮﺳ ﺢﻄﺳﯽCEA وCA15-3 .ﺪﺷ هداد نﺎﺸﻧ نﺎﺘﺴﭘ نﺎﻃﺮﺳ ﻒﻠﺘﺨﻣ ﻞﺣاﺮﻣ ﺎﺑ
رادﺎﻨﻌﻣ طﺎﺒﺗرا ﺮﺿﺎﺣ ﻪﻌﻟﺎﻄﻣ رديﺑﯿﻦﻣﺮﺳ ﺢﻄﺳﯽCA27-29ﺎﺘﻧ .ﺖﺷاﺪﻧ دﻮﺟو نﺎﺘﺴﭘ نﺎﻃﺮﺳ ﻒﻠﺘﺨﻣ ﻞﺣاﺮﻣ وﯾﺞاﯾﻦﻟﺎﻄﻣﻪﻌﻣ نﺎﺸﻧﯽﻣ ﻪﮐ ﺪﻫدﯽ زا ناﻮﺗ
CEA وCA15-3اﺮﺑيﭘﯿﺶﺑﯿﻨﯽزرا وﯾﺑﺎﯽﺳﺎﺴﺣ ﺖﻠﻋ ﻪﺑ ﻪﺘﺒﻟا .دﺮﮐ هدﺎﻔﺘﺳا نﺎﺘﺴﭘ نﺎﻃﺮﺳﯿﺖ70ﺪﺻرديCA15-3 و50ﺪﺻرديCEA زا هدﺎﻔﺘﺳا
ﺎﻫ شوريدﯾﺮﮕﺨﺸﺗﯿﺼﯽﻣاﺰﻟاﯽﻣ ﺮﻈﻧ ﻪﺑﯽ.ﺪﺳر
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Background: This study measured blood level of CEA, CA15-3, and CA27-29 markers in different stages
of Breast cancer to determine significant relationship between stage of Breast cancer and blood
markers. Material and methods: The present study sectional study was studied 180 patients suffered
from breast cancer. Results: In this present study 57.8%of patients were studied because of mass and
52.8% because of micro-calcification in mammography. %25 of patients had positive Family history.
Patients in this study were all present in every stages of breast cancer. The pathology of 70% of patients
had ductal carcinoma and the rest were from different kinds. 10/5% of patients had metastatic tumor.
Significant relation was found between serum Levels of CEA, CA15-3 and stages of breast cancer (p=
0/001, p= 0/0001 respectively). No significant relationship between serum level of CA27-29 and
different stages of breast cancer was found.   Discussion: Significant and positive relation was found
between serum levels of CEA, CA15-3 with different stages of breast cancer. Also, there wasn’t a
significant relation between serum level of CA27-29 and different stages of breast cancer. The results
were considered that we can use CAE and CA15-3 for predicting and evaluating of breast cancer.
Although, because of 70% sensitivity of CA15-3 and 50% of CEA using other diagnostic methods
seemed obligatory.
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